PaclitaxelWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Alcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGenomicTestingGeneMutationIntraductalPapillomaPARPInhibitorsSelf-examinationApoptosisKappaEpsilonAyurvedaAdjuvantTherapyRadiotherapyDown-StagingMultifocalTumorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAntibodyTherapyECOGScoreCAMAnastrozolePalbociclibBiopsyCalcificationsAntiemeticMorpheaHerceptinAdenocarcinomaAlopeciaOligometastasesCMFChemotherapyMRIAbsoluteRiskER+RADPI3KinaseInhibitorsCachexiaLumpACChemotherapyBOCAMastectomyEstradiolCo-survivorHormoneReplacementTherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55TumorGrade5-FluorouracilCytostaticMetastasisCystmTORInhibitorsNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltWomen ages40+ shouldhave a clinicalbreast examat least yearlyFamilyHistoryKi-67RateDoseDenseTherapyRaloxifeneDocetaxelCapecitabineStagingDoxorubicinLCISChemopreventionFlowCytometryLumpectomyMastodyniaPhyllodesTumorProgestinAromataseInhibitorsFibroadenomaIn-situCarcinomaTriple +/-BreastCancerPathologicResponseGeneticPredispositionBreastTomosynthesisHormoneReceptorStatusDefinitiveSurgery1 in 8womenEstrogenGuaranteedRenewableInsuranceHER-2BRCAGeneLymphoscintigraphyPrecisionMedicineGermlineMutationTamoxifenPalpationPhysicalactivity mayreduce therisk of breastcancersRelapseBrachytherapyMethotrexateBreastCancerCheckpointInhibitorImmunotherapyMegestrolAcetateAxillarySamplingCDK4/6InhibitorsSERMLapatinibOvarianSuppressionMultimodalityTherapyGeneticCounselingLymphNodeStatusER-BI-RADSTyrosine-KinaseInhibitorBilateralProphylacticMastectomyGailModelAdvocacyCyclophosphamideBevacizumabCytotoxicEGFRDimplingPagetDiseaseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenChemotherapyAngiogenesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FISHPaclitaxelWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Alcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGenomicTestingGeneMutationIntraductalPapillomaPARPInhibitorsSelf-examinationApoptosisKappaEpsilonAyurvedaAdjuvantTherapyRadiotherapyDown-StagingMultifocalTumorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAntibodyTherapyECOGScoreCAMAnastrozolePalbociclibBiopsyCalcificationsAntiemeticMorpheaHerceptinAdenocarcinomaAlopeciaOligometastasesCMFChemotherapyMRIAbsoluteRiskER+RADPI3KinaseInhibitorsCachexiaLumpACChemotherapyBOCAMastectomyEstradiolCo-survivorHormoneReplacementTherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55TumorGrade5-FluorouracilCytostaticMetastasisCystmTORInhibitorsNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltWomen ages40+ shouldhave a clinicalbreast examat least yearlyFamilyHistoryKi-67RateDoseDenseTherapyRaloxifeneDocetaxelCapecitabineStagingDoxorubicinLCISChemopreventionFlowCytometryLumpectomyMastodyniaPhyllodesTumorProgestinAromataseInhibitorsFibroadenomaIn-situCarcinomaTriple +/-BreastCancerPathologicResponseGeneticPredispositionBreastTomosynthesisHormoneReceptorStatusDefinitiveSurgery1 in 8womenEstrogenGuaranteedRenewableInsuranceHER-2BRCAGeneLymphoscintigraphyPrecisionMedicineGermlineMutationTamoxifenPalpationPhysicalactivity mayreduce therisk of breastcancersRelapseBrachytherapyMethotrexateBreastCancerCheckpointInhibitorImmunotherapyMegestrolAcetateAxillarySamplingCDK4/6InhibitorsSERMLapatinibOvarianSuppressionMultimodalityTherapyGeneticCounselingLymphNodeStatusER-BI-RADSTyrosine-KinaseInhibitorBilateralProphylacticMastectomyGailModelAdvocacyCyclophosphamideBevacizumabCytotoxicEGFRDimplingPagetDiseaseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenChemotherapyAngiogenesisFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.FISH

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Paclitaxel
  2. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  3. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  4. Genomic Testing
  5. Gene Mutation
  6. Intraductal Papilloma
  7. PARP Inhibitors
  8. Self-examination
  9. Apoptosis
  10. Kappa Epsilon
  11. Ayurveda
  12. Adjuvant Therapy
  13. Radiotherapy
  14. Down-Staging
  15. Multifocal Tumors
  16. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  17. Antibody Therapy
  18. ECOG Score
  19. CAM
  20. Anastrozole
  21. Palbociclib
  22. Biopsy
  23. Calcifications
  24. Antiemetic
  25. Morphea
  26. Herceptin
  27. Adenocarcinoma
  28. Alopecia
  29. Oligometastases
  30. CMF Chemotherapy
  31. MRI
  32. Absolute Risk
  33. ER+
  34. RAD
  35. PI3 Kinase Inhibitors
  36. Cachexia
  37. Lump
  38. AC Chemotherapy
  39. BOCA
  40. Mastectomy
  41. Estradiol
  42. Co-survivor
  43. Hormone Replacement Therapy
  44. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  45. Tumor Grade
  46. 5-Fluorouracil
  47. Cytostatic
  48. Metastasis
  49. Cyst
  50. mTOR Inhibitors
  51. Neoadjuvant Therapy
  52. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  53. Women ages 40+ should have a clinical breast exam at least yearly
  54. Family History
  55. Ki-67 Rate
  56. Dose Dense Therapy
  57. Raloxifene
  58. Docetaxel
  59. Capecitabine
  60. Staging
  61. Doxorubicin
  62. LCIS
  63. Chemoprevention
  64. Flow Cytometry
  65. Lumpectomy
  66. Mastodynia
  67. Phyllodes Tumor
  68. Progestin
  69. Aromatase Inhibitors
  70. Fibroadenoma
  71. In-situ Carcinoma
  72. Triple +/- Breast Cancer
  73. Pathologic Response
  74. Genetic Predisposition
  75. Breast Tomosynthesis
  76. Hormone Receptor Status
  77. Definitive Surgery
  78. 1 in 8 women
  79. Estrogen
  80. Guaranteed Renewable Insurance
  81. HER-2
  82. BRCA Gene
  83. Lymphoscintigraphy
  84. Precision Medicine
  85. Germline Mutation
  86. Tamoxifen
  87. Palpation
  88. Physical activity may reduce the risk of breast cancers
  89. Relapse
  90. Brachytherapy
  91. Methotrexate
  92. Breast Cancer
  93. Checkpoint Inhibitor
  94. Immunotherapy
  95. Megestrol Acetate
  96. Axillary Sampling
  97. CDK4/6 Inhibitors
  98. SERM
  99. Lapatinib
  100. Ovarian Suppression
  101. Multimodality Therapy
  102. Genetic Counseling
  103. Lymph Node Status
  104. ER-
  105. BI-RADS
  106. Tyrosine-Kinase Inhibitor
  107. Bilateral Prophylactic Mastectomy
  108. Gail Model
  109. Advocacy
  110. Cyclophosphamide
  111. Bevacizumab
  112. Cytotoxic
  113. EGFR
  114. Dimpling
  115. Paget Disease
  116. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  117. Chemotherapy
  118. Angiogenesis
  119. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  120. FISH